SVA Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
SVA Wealth Management's GILD Position: Q4 2020 in Review
SVA Wealth Management reduced its Gilead Sciences (GILD) stake by 17% in Q4 2020, selling an estimated $393K and leaving 32,341 shares worth $1.88M. The position accounts for 0.16% of the portfolio, ranked #101.
SVA Wealth Management first reported a position in GILD in Q4 2015 and has held it in 18 quarters since. The position peaked at $3.24M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- SVA Wealth Management held 32,341 shares of Gilead Sciences worth $1.88M as of Q4 2020.
- SVA Wealth Management sold 6,506 Gilead Sciences shares in Q4 2020, an estimated $393K.
- Gilead Sciences made up 0.16% of SVA Wealth Management's portfolio in Q4 2020, its #101 holding.
- SVA Wealth Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 18 quarters since.
- SVA Wealth Management's Gilead Sciences position peaked at $3.24M in Q2 2020.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.